Muutke küpsiste eelistusi

Handbook of Nuclear Medicine and Molecular Imaging for Physicists: Radiopharmaceuticals and Clinical Applications, Volume III [Kõva köide]

(Department Medical Radiation Physics, Lund University, Sweden)
  • Formaat: Hardback, 374 pages, kõrgus x laius: 280x210 mm, kaal: 850 g, 42 Tables, black and white; 78 Line drawings, black and white; 75 Halftones, black and white; 153 Illustrations, black and white
  • Sari: Series in Medical Physics and Biomedical Engineering
  • Ilmumisaeg: 25-Apr-2022
  • Kirjastus: CRC Press
  • ISBN-10: 1138593311
  • ISBN-13: 9781138593312
Teised raamatud teemal:
  • Formaat: Hardback, 374 pages, kõrgus x laius: 280x210 mm, kaal: 850 g, 42 Tables, black and white; 78 Line drawings, black and white; 75 Halftones, black and white; 153 Illustrations, black and white
  • Sari: Series in Medical Physics and Biomedical Engineering
  • Ilmumisaeg: 25-Apr-2022
  • Kirjastus: CRC Press
  • ISBN-10: 1138593311
  • ISBN-13: 9781138593312
Teised raamatud teemal:
This state-of-the-art handbook, the third and final in a series that provides medical physicists with a comprehensive overview into the field of nuclear medicine, focuses on highlighting the production and application of radiopharmaceuticals. With this, the book also describes the chemical composition of these compounds, as well as some of the main clinical applications where radiopharmaceuticals may be used.

Following an introduction to the field of radiopharmacy, three chapters in this book are dedicated towards in-depth descriptions of common radionuclides and radiopharmaceuticals used during diagnostic studies utilizing planar/Single Photon Emission Computed Tomography (SPECT) imaging, in addition to during Positron Emission Tomography (PET) imaging, and, finally, radiotherapy. These chapters are followed by those describing procedures relating to quality control and manufacturing (good manufacturing practices) also encompassing aspects such as environmental compliance. Furthermore, this volume illustrates how facilities handling these chemicals should be designed to comply with set regulations.

Like many pharmaceuticals, the development of radiopharmaceuticals relies heavily on the use of mouse models. Thus, the translation of radiopharmaceuticals (i.e., the process undertaken to assure that the functionality and safety of a newly developed drug is maintained also in a human context), is covered in a later chapter. This is followed by a chapter emphasising the importance of safe waste disposal and how to assure that these procedures meet the requirements set for the disposal of hazardous waste.

Several chapters have also been dedicated towards describing various medical procedures utilizing clinical nuclear medicine as a tool for diagnostics and therapeutics. As physicists may be involved in clinical trials, a chapter describing the procedures and regulations associated with these types of studies is included. This is followed by a chapter focusing on patient safety and another on an imaging modality not based on ionizing radiation ultrasound. Finally, the last chapter of this book discusses future perspectives of the field of nuclear medicine.

This text will be an invaluable resource for libraries, institutions, and clinical and academic medical physicists searching for a complete account of what defines nuclear medicine.











The most comprehensive reference available providing a state-of-the-art overview of the field of nuclear medicine





Edited by a leader in the field, with contributions from a team of experienced medical physicists, chemists, engineers, scientists, and clinical medical personnel





Includes the latest practical research in the field, in addition to explaining fundamental theory and the field's history
Preface ix
Editor xi
Contributors xiii
Chapter 1 Principles behind Radiopharmacy
1(12)
Thuy A. Tran
Erik Samen
Chapter 2 Radiopharmaceuticals for Diagnostics: Planar/SPECT
13(14)
Jim Ballinger
Jacek Koziorowski
Chapter 3 Radiopharmaceuticals for Diagnostics: PET
27(12)
Philip H. Elsinga
Chapter 4 Radiopharmaceuticals for Radionuclide Therapy
39(16)
Meltem Ocak
Emre Demirci
Jessie R. Nedrow
Rebecca Krimins
Chapter 5 Design Considerations for a Radiopharmaceutical Production Facility
55(4)
Nic Gillings
Chapter 6 Methods and Equipment for Quality Control of Radiopharmaceuticals
59(12)
Rolf Zijlma
Danique Giesen
Yvette Kruiter
Philip H. Elsinga
Gert Luurtsema
Chapter 7 Environmental Compliance and Control for Radiopharmaceutical Production: Commercial Manufacturing and Extemporaneous Preparation
71(16)
Ching-Hung Chiu
Ya-Yao Huang
Wen-Yi Chang
Jacek Koziorowski
Chapter 8 GMP: Rules and Recommendations
87(8)
Oliver Neels
Chapter 9 Management of Radioactive Waste in Nuclear Medicine
95(6)
Lena Jonsson
Hanna Holstein
Chapter 10 Translation of Radiopharmaceuticals: Mouse to Man
101(16)
Pedro Fragoso Costa
Latifa Rbah-Vidal
An Aerts
Fijs W.B. van Leeuwen
Margret Schottelius
Chapter 11 Radionuclide Bone Scintigraphy
117(22)
Kanhaiyalal Agrawal
Gopinath Gnanasegaran
Chapter 12 Radionuclide Examination of the Kidneys
139(34)
Martin Somal
Jin Trnka
Chapter 13 Neuroimaging in Nuclear Medicine
173(16)
Anne Larsson Strbmvall
Susanna Jakobson Mo
Chapter 14 Methodology and Clinical Implementation of Ventilation/Perfusion Tomography for Diagnosis and Follow-up of Pulmonary Embolism and Other Pulmonary Diseases: Clinical Use of Hybrid V/P SPECT-CT
189(12)
Marika Bajc
Ari Lindqvist
Chapter 15 Myocardial Perfusion Imaging
201(12)
Elin Tragardh
David Minarik
Mark Lubberink
Chapter 16 Infection and Inflammation
213(18)
Erik H. J. G. Aarntzen
Andor W.J. M. Glaudemans
Chapter 17 Special Considerations in Pediatric Nuclear Medicine
231(12)
Sofie Lindskov Hansen
Soren Holm
Liselotte Højgaard
Lise Borgwardt
Chapter 18 Antibody-based Radionuclide Imaging
243(12)
Steffie M. B. Peters
Erik H. J. G. Aarntzen
Sandra Heskamp
Chapter 19 Radionuclide-based Diagnosis and Therapy of Prostate Cancer
255(50)
Sven-Erik Strand
Mohamed Altai
Joanna Strand
David Ulmert
Chapter 20 Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumours
305(8)
Anna Sundlov
Katarina Sjogreen Gleisner
Chapter 21 Lymphoscintigraphy
313(12)
Rimma Axelsson
Maria Holstensson
Ulrika Estenberg
Chapter 22 Diagnostic Ultrasound
325(12)
Tomas Jansson
Chapter 23 Clinical Trials: Purpose and Procedures
337(8)
Anna Sundlov
Chapter 24 Introduction to Patient Safety and Improvement Knowledge
345(12)
Tomas Kirkhorn
Chapter 25 Closing Remarks
357
Laszlo Pavics
Michael Ljungberg is a Professor at Medical Radiation Physics, Lund, Lund University, Sweden. He started his research in the Monte Carlo field in 1983 through a project involving a simulation of whole-body counters but later changed the focus to more general applications in nuclear medicine imaging and SPECT. Parallel to his development of the Monte Carlo code, SIMIND, he began working in 1985 with quantitative SPECT and problems related to attenuation and scatter. After earning his PhD in 1990, he received a research assistant position that allowed him to continue developing SIMIND for quantitative SPECT applications and to establish successful collaborations with international research groups. At this time, the SIMIND program became used world-wide. Dr. Ljungberg became an associate professor in 1994 and, in 2005, after working clinically as a nuclear medicine medical physicist, received a full professorship in the Science Faculty at Lund University. He became the Head of the Department of Medical Radiation Physics at Lund in 2013 and a full professor in the Medical Faculty in 2015.

Aside from the development of SIMIND including new camera systems such as CZT detectors his research includes an extensive project in oncological nuclear medicine. In this project, he and colleagues developed dosimetry methods based on quantitative SPECT, Monte Carlo absorbed-dose calculations, and methods for accurate 3D dose planning for internal radionuclide therapy. Lately, his work has focused on implementing Monte Carlobased image reconstruction in SIMIND. He is also involved in the undergraduate education of medical physicists and bio-medical engineers and supervises MSc and PhD students. In 2012, Professor Ljungberg became a member of the European Association of Nuclear Medicines task group on Dosimetry and served that association for six years. He has published over a hundred original papers, 18 conference proceedings, 18 books and book chapters, and 14 peer-reviewed papers.